AstraZeneca

Update in progress

AZN (NYSE)

Company RatingNeutral
SectorHealthcare
IndustryDrug Manufacturers - General

AstraZeneca PLC is a biopharmaceutical company focused on discovering, developing, manufacturing, and selling prescription medicines. It offers a broad portfolio across oncology, cardiovascular, renal and metabolism, respiratory and immunology, vaccines, and rare diseases. The company serves primary and specialty care through distributors and local offices worldwide. Headquartered in Cambridge, UK, it was formerly Zeneca and was incorporated in 1992. It has strategic research collaborations with Tempus, Pathos, and CSPC.

Company score

Sentiment: 2.20; SentimentMeasures the overall tone of recent coverage and discussion about the company.−10 negative · 0 neutral · +10 positive
Environment: 1.53; EnvironmentAssesses the company’s environmental impact, risks, and sustainability practices.−10 negative · 0 neutral · +10 positive
Social: 2.09; SocialAssesses the company’s influence on employees, customers, communities, and wider society.−10 negative · 0 neutral · +10 positive
Governance: -0.44; GovernanceAssesses leadership, accountability, transparency, and business ethics.−10 negative · 0 neutral · +10 positive
Sustainability: 1.05; SustainabilityCombines environmental, social, and governance signals into an overall sustainability score.−10 negative · 0 neutral · +10 positive
Impact Score: 1.62; Impact ScoreCombines sentiment and sustainability performance into an assessment of the company’s overall impact.−10 negative · 0 neutral · +10 positive